CD4 and pneumocystosis: Although the MBDS does not provide clinical data on therapy (cART or PCP prophylaxis) nor CD4+ T cell values with which to examine any associations with PCP incidence and mortality, it is possible that patients with PCP were newly diagnosed with HIV at the time or were HIV-positive patients not receiving cART or PCP prophylaxis [1,2,6,34].